New patent for Astrazeneca drug CALQUENCE

October 31, 2023 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for CALQUENCE Calquence is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eight patents protecting…

The post New patent for Astrazeneca drug CALQUENCE appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.